Future Prescriber
Future Prescriber provides information on new drugs from early development through to launch. It also covers significant developments with drugs that are currently available and discusses the potential impact of prescribing policy changes. Future Prescriber is designed for decision makers in Trusts and Strategic Health Authorities and also lead-prescribing members of PCTs, LHCCs and LHGs. Future Prescriber meets the growing information needs of decision makers and planners in the NHS and ensures that these decision makers are well informed and prepared for the changes brought about by important new product initiatives. Access to all content is free to healthcare professionals following registration.
Current Issue
- Anti-TNF-alpha drugs - moving into the mainstream?
- Published online on Dec 24, 2009
- Quetiapine: a new option in bipolar depression
- Published online on Dec 24, 2009
- Certolizumab pegol: a new option for rheumatoid arthritis
- Published online on Dec 24, 2009
- Comparing notes: cancer leaders discuss the latest advances
- Published online on Dec 24, 2009
- New developments in multiple sclerosis and pain management
- Published online on Dec 24, 2009
Supplements
Latest News
- Roflumilast: a novel approach to the management of COPD
- Published on May 28, 2009
Nycomed have submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for roflumilast (Daxas) as a once-daily...
- CYT006-AngQb fails to reduce blood pressure in phase IIa study
- Published on May 12, 2009
A double-blind, placebo-controlled, phase IIa study has failed to demonstrate that Cytos Biotechnology’s hypertension vaccine, CYT006-AngQb, is...
- New data for lipid modifying drug
- Published on May 12, 2009
A recent phase III study has found that patients with primary hypercholesterolaemia or mixed dyslipidaemia experienced reduced LDL-C of almost 48%,...

